Keele University
Newcastle-under-Lyme, Staffordshire, ST5 5BG, United Kingdom
NCT Number: NCT05422937
Introduction:
While there is a substantial body of knowledge about acute Covid-19 in children and young people (CYP), less is known about long-COVID, where symptoms continue beyond four weeks, particularly since the most recent wave of the Omicron variant and the UK childhood vaccination programme roll out. This study aims to provide a picture of longer-term effects of an acute Covid-19 infection in CYP and identify their needs.
Methods and analysis:
The study comprises an observational prospective cohort study and a linked qualitative study. The cohort study will identify CYP aged 8-17 years in the West Midlands of England and, irrespective of Covid-19 status, invite them to complete an online questionnaire at point of recruitment, and after 3, 6, 9 and 12 months. CYP who have experienced long-term effects of COVID-19 will be invited to interview and, those who are currently experiencing symptoms, will be invited to record their experiences in a diary. Adults working in professional or third sector/voluntary roles with CYP will be invited to take part in a focus group to explore the perceived impact of Long-COVID on the wider experience of CYP. Approximately 900 participants will be needed for the cohort study to ensure the sample size is suitable, with approximately 20 CYP invited to interview and approximately 8 professionals invited to a focus group. Descriptive statistics will be used to describe incidence rates of symptoms and symptom resolution trajectories, and comparisons made between exposed and non-exposed groups. Logistic regression models will be used to estimate associations between candidate predictors and development of Long-COVID at each follow-up point. Linear regression will be used to estimate associations between candidate predictors and poor outcome in terms of health-related quality of life, as described by the KIDSCREEN10. Qualitative data will be analysed thematically using the constant comparison method.
Ethics and dissemination:
Research Ethics Committee and Health Research Authority approvals will be sought. Information about where to seek support will be provided to participants to mitigate against risks of harm. Study findings will be presented at conferences and published in open access journals.
Looking for future studies?
Notify Me8 year–17 year
All sexes
Observational
Newcastle-under-Lyme, Staffordshire, ST5 5BG, United Kingdom
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for Cohort:
Exclusion criteria
for Cohort:
Inclusion criteria
for Interviews:
Inclusion criteria
for Focus Group:
Time frame: 12 months
Global health-related quality of life measure. Minimum value 1 and maximum value 5 per question. Higher values indicate better quality of life.
Time frame: 12 months
Based on the ISARIC-WHO COVID-19 Survey and NICE COVID rapid evidence review
Time frame: 12 months
Contacts with and attendances at GP surgery, A&E attendance, referrals to secondary care (including paediatric fatigue clinic), hospital admission, contact with counselling / mental health services
Time frame: 12 months
Any new medical conditions diagnosed since COVID (e.g. asthma, type 1 diabetes)
Time frame: 12 months
Days absent and difficulties completing school work
Keele University
Other
Acronym: SPLaT-19
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04330261
COVID-19, Coronaviridae Infections
Calgary, Alberta, Canada
View Trial DetailsNCT06482281
COVID-19, Childhood Cancer
Stockholm, Sweden
View Trial DetailsNCT04794829
COVID-19, Coronaviridae Infections
Bethesda, Maryland, United States
View Trial DetailsNCT07552779
COVID-19, COVID-19 (Coronavirus Disease 2019)
Brussels, Bruxelles-capitale, Région de, Belgium
View Trial Details